Feature | January 02, 2013

MITA says slashed reimbursements and new medical device tax will cost American jobs and medical technology leadership

January 2, 2013 — The Medical Imaging and Technology Alliance (MITA) said that failure to delay the new medical device excise tax, along with Medicare cuts for imaging and radiation therapy services passed by Congress as part of the “fiscal cliff” package, will hinder patients’ access to early disease detection and therapy services and threaten American medical technology jobs.

The legislation reduces physician office Medicare payments for advanced imaging services by $800 million and hospital reimbursements for radiation therapy by $300 million over 10 years. These cuts are in addition to the more than $1 billion in cuts for imaging and radiation therapy services put in place earlier in 2012.

Further, MITA said that Congress’ refusal to address the 2.3 percent medical device tax as part of the fiscal cliff package will harm America’s global leadership in the development of innovative medical imaging technologies and is estimated to cost up to 43,000 medical technology jobs in the United States

“When you add up all the Medicare cuts and Congress’ reluctance to address the $30 billion medical device tax, this legislation produces a devastating impact that harms patient access to care, moves manufacturing jobs overseas and threatens America’s leadership in medical research and development,” said Gail Rodriguez, MITA’s executive director.

“We hope the administration and congressional leaders will take notice of the growing bipartisan opposition to the job-killing device tax and immediately repeal or delay it,” Rodriguez said. "Further, Congress should reverse Medicare cuts since the data clearly show that imaging use per beneficiary is on the decline. It is arbitrary and capricious for Congress to cut imaging and radiation therapy reimbursements without a full understanding of how those cuts negatively impact their constituents’ ability to receive imaging and radiation therapy that saves lives.”

A MITA report released in October shows that imaging utilization per Medicare beneficiary declined by 5.12 percent since 2009 and spending on imaging services for each Medicare beneficiary has dropped 16.7 percent since 2006. That report was echoed in a policy brief from the Harvey L. Neiman Health Policy Institute that shows medical imaging utilization and spending has declined since 2006, while the average length of hospital stays in the United States has increased.

For more information: www.medicalimaging.org/category/mita-news


Related Content

News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

March 28, 2024 — RefleXion Medical, Inc., a therapeutic oncology company, and Limbus AI, Inc., a provider of software ...

Time March 28, 2024
arrow
News | Artificial Intelligence

March 18, 2024 — RamSoft, a global leader in novel cloud-based RIS/PACS radiology solutions for imaging centers and ...

Time March 18, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
News | Radiology Imaging

March 5, 2024 — Life Guard Imaging, a pioneering leader in preventative imaging services, is thrilled to announce its ...

Time March 05, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — Median Technologies announced that the Company will be participating and speaking at the premier ...

Time February 27, 2024
arrow
News | X-Ray

February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the ...

Time February 26, 2024
arrow
Subscribe Now